pubrio
ALAR Pharmaceuticals Inc. logo

ALAR Pharmaceuticals Inc.

Public
alarpharm.com
製藥產業9 employeesFounded 2016🇹🇼 台灣

Alar Pharmaceuticals Inc. (abbreviated as Alar), a new drug development company, was established in 2016. We focus on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and major depressive disorder.

成立年份
2016
員工
9
行業
製藥產業
公司類型
Public Company
股票
two: 6785.TWO
總部
🇹🇼Keya Rd., Daya Dist., 5f., No. 32, Taichung City, 428015, Tw (+1)
專長
製藥產業生物技術醫療保健

擴張情報

全新 · Pubrio 獨家

我們正在追蹤 ALAR Pharmaceuticals Inc. 的市場擴張

全球擴張

即時
階段
探索中投入中進入中營運中
值得了解

關於 ALAR Pharmaceuticals Inc. 的常見問題

關於 ALAR Pharmaceuticals Inc. 業務、市場及增長訊號的快速解答。

Alar Pharmaceuticals Inc. (abbreviated as Alar), a new drug development company, was established in 2016. We focus on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and major depressive disorder.

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。